Tasigna
/
Tasigna is a tyrosine kinase inhibitor indicated for the treatment of chronic myeloid leukemia (CML) in patients with specific genetic mutations. It is administered as an oral tablet and is available by prescription only. Patients are advised to monitor for potential side effects, including the risk of QT prolongation, and should not use Tasigna if they have a history of hypersensitivity to nilotinib or any of its components.
FAQs about Tasigna
What should I do if I miss a dose?
If you miss a dose of Tasigna, take it as soon as you remember on the same day. However, if it is almost time for your next dose, skip the missed dose and continue with your regular schedule. Do not take two doses at the same time to make up for a missed dose. This information is found in the Patient Counseling Information section of the label.
Can I stop taking Tasigna suddenly?
You should not stop taking Tasigna without consulting your healthcare provider. Abrupt discontinuation may lead to a loss of treatment effect and could result in disease progression. This warning is highlighted in the Warnings and Precautions section of the label.
How should I store Tasigna?
Tasigna should be stored at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in its original container and protect it from moisture and light. This storage information is provided in the Storage section of the label.
25
commonly-prescribed
medication.